key: cord-0831832-v866jpww
authors: Porto, L. C.; Costa, C. H.; Nunes, A. S.; Bouzas, I.; Ferreira, T.; Porto, V. M.; Secco, D. A.; COVID-19 PPC group,; Rufino, R.
title: Clinical and laboratory characteristics in outpatient diagnosis of COVID-19 in healthcare professionals in Rio de Janeiro, Brazil
date: 2020-10-26
journal: nan
DOI: 10.1101/2020.10.22.20217851
sha: 4bcd64197200cb8ce454db2fbb452600d07cdb69
doc_id: 831832
cord_uid: v866jpww

Aims: This study aimed to identify the symptoms associated with early-stage SARS-CoV-2 (COVID-19) infections in healthcare professionals (HCP) using both clinical and laboratory data. Methods: A total of 1,297 patients, admitted between March 18 and April 8, 2020, were stratified according to their risk of developing COVID-19 using their responses to a questionnaire designed to evaluate symptoms and risk conditions. Results: Anosmia/hyposmia (p <0.0001), fever (p<0.0001), body pain (p<0.0001), and chills (p=0.001) were all independent predictors for COVID-19, with a 72% estimated probability for detecting COVID-19 in nasopharyngeal swab samples. Leukopenia, relative monocytosis, decreased eosinophil values, CRP, and platelets were also shown to be significant independent predictors for COVID-19. Conclusions: The significant clinical features for COVID-19 were identified as anosmia, fever, chills, and body pain. Elevated CRP, leukocytes under 5,400 x 109/L, and relative monocytosis (>9%) were common among patients with a confirmed COVID-19 diagnosis. These variables may help, in the absence of RT-PCR tests, to identify possible COVID-19 infections during pandemic outbreaks.

COVID-19 detection. Healthcare professional data was analyzed, significant clinical features 18 were anosmia, fever, chills and body pain. Elevated CRP, leukopenia and monocytosis were 19 common in COVID- 19. 20 . CC-BY-NC-ND 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted October 26, 2020. ; https://doi.org/10.1101/2020. 10.22.20217851 doi: medRxiv preprint Abstract 1 Aims: This study aimed to identify the symptoms associated with early stage SARS-CoV-2 2 (COVID- 19) infections in healthcare professionals (HCP) using both clinical and laboratory data. 3

Methods: A total of 1,297 patients, admitted between March 18 and April 8, 2020, were 4 stratified according to their risk of developing COVID-19 using their responses to a 5 questionnaire designed to evaluate symptoms and risk conditions. 6

Results: Anosmia/hyposmia (p <0.0001), fever (p<0.0001), body pain (p<0.0001), and chills 7 (p=0.001) were all independent predictors for COVID-19, with a 72% estimated probability for 8

detecting COVID-19 in nasopharyngeal swab samples. Leukopenia, relative monocytosis, 9 decreased eosinophil values, CRP, and platelets were also shown to be significant independent 10 predictors for COVID- 19. 11 Conclusions: The significant clinical features for COVID-19 were identified as anosmia, fever, 12 chills, and body pain. Elevated CRP, leukocytes under 5,400 x 10 9 /L, and relative monocytosis 13 (>9%) were common among patients with a confirmed COVID-19 diagnosis. These variables 14 may help, in the absence of RT-PCR tests, to identify possible COVID-19 infections during 15 pandemic outbreaks. 16

Keywords: diagnosis, leukocytes, biochemistry, COVID-19, healthcare professionals, leukocytes, 17 anosmia, body pain, C-reactive protein, monocytes, fever, chills 18 19 . CC-BY-NC-ND 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted October 26, 2020. ; https://doi.org/10.1101/2020. 10 is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted October 26, 2020. ; https://doi.org/10.1101/2020. 10.22.20217851 doi: medRxiv preprint Real-time PCR SARS-COV-2 detection and laboratory testing 1 RNA was extracted from the samples according to both the COVID-19 infection and laboratory 2 detection for the SARS-COV-2 guidelines [12] . Specific real-time reverse transcription 3 polymerase chain reaction (RT-PCR) assays were performed using commercial kits or previously 4 designed nCoVqRT-PCR kits (Biomanguinhos, Fiocruz, Rio de Janeiro, and Instituto de Biologia 5 Molecular do Paraná, Paraná) approved by the Brazilian Vigilance (ANVISA) group within the 6 Histocompatibility and Cryopreservation Laboratory at UERJ. 7

Peripheral blood tests were performed by the Pathology Service of the Piquet Carneiro Polyclinic 8 using several automated systems. The complete blood counts were carried out using a SYSMEX 9

XT1800i, while the C-reactive protein (CRP; immunoturbidimetric), creatinine (CR, picrate 10 kinetic), lactate dehydrogenase (LDH; IFCC) , aspartate and alanine aminotransferases (AST and 11 ALT; NAPH), and creatine phosphokinase (CK; N-acetyl L-cysteine) assays were performed using 12 the Architect c8000 Equipment from Abbott. 13 14 All the questionnaire, nursing and medical consultation records, and laboratory findings were 15 added to the electronic media files for each patient. This data was then used to ascertain the 16 epidemiological and symptom data for the larger cohort. All data were checked by two 17 independent physicians (LCP and IB). 18 19 The quantitative peripheral blood tests were compared using ANOVA or the Mann-Whitney U 20 test and the Kruskal Wallis tests when appropriate. The categorical variables were expressed as 21 numbers (%) and compared using the Fisher's exact test. Differences were considered significant 22 at a p-value of < 0.05 using a one-tailed test. Tukey or Dunn test was applied when multiple 23 comparisons were analyzed, respectively for normal or nonparametric variables. The date of 24 testing was also grouped by week. In the multivariate analyses, Binary Logistic Regression (LR) 25 . CC-BY-NC-ND 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted October 26, 2020. ; https://doi.org/10.1101/2020.10.22.20217851 doi: medRxiv preprint was used to identify the clinical, laboratory and independent signs or symptoms that could 1 explain (or predict) the presence of the SARS-COV-2 in each sample. The selection process was 2 applied using a stepwise process which allowed us to select the smallest subgroup of 3 independent variables that best explained any particular outcome. All analyses were performed 4 using the SPSS 26.0 software. 5

Demographic and laboratory characteristics linked to positive COVID-19 test results 7 Risk factors related to the COVID-19 NPS results are summarized in Tables 2 and 3. 8 is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted October 26, 2020. ; https://doi.org/10.1101/2020. 10 is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted October 26, 2020. ; https://doi.org/10.1101/2020. 10.22.20217851 doi: medRxiv preprint Cough, headache, body ache (including myalgia at rest or during minimal physical effort), fever, sore throat, coryza, and tiredness were common symptoms, present in more than a third of the patients in the cohort.

These symptoms were common to both the undetected, inconclusive, and SARS-COV-2-positive groups.

However, chills, anosmia or hyposmia, nausea or vomiting, and abdominal pain, although less frequent, were more common in individuals with the SARS-COV-2-positive results (p<0.001) than in patients with no detectable infection.

The respiratory and cardiac frequencies, temperature, O2 saturation, and laboratory results for this cohort are summarized in Table 4 . CRP, LDH, AST, and ALT levels were all shown to be elevated in COVID-19 patients, while leukometry values were shown to differ between individuals regardless of the SARS-COV-2 SNF detection result.

When we applied the logistic regression, we observed that anosmia/hyposmia (OR: 2.38, 95%IC: 1.78-3.19, p < 0.0001), fever (OR: 2.13, 95%IC: 1.63-2.79, p < 0.0001), body pain (OR: 2.11, 95%IC: 1.59-2.82, p < 0.0001), and chills (OR: 1.70, 95%IC: 1.23-2.34, p = 0.001), in this specific order, were independent predictors for COVID- 19 . The other signs and symptoms did not make a significant contribution, when evaluated using the 95% confidence interval. The estimated probability of COVID-19 detection in patients presenting with these four signs and symptoms (fever, body pain, anosmia-hyposmia, and chills) was 72% when evaluated using a model adjusted for logistic regression.

When the laboratory test results (906 complete records) were evaluated using logistic regression leukocytes (p<0.0001), monocytes (p<0.0001), eosinophils (p<0.0001), CRP (p=0.001), and platelets (p=0.003), in this specific order, were significant independent predictors for COVID-19. The other laboratory variables did not make a significant contribution to predicting a SARS-CoV-2 positive sample at 95% confidence interval. For the final model, we considered the following variables: age, sex, onset of symptoms, education, laboratory results, and clinical signs and symptoms. Table 5 provides the final regression model, using 770 complete records to link specific data to SARS-COV-2 detection. We observed that leukopenia, monocytosis (%), eosinophil decrease %, onset of symptoms, increased CRP, presence of fever, decreased number of platelets, is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted October 26, 2020. ; https://doi.org/10.1101/2020.10.22.20217851 doi: medRxiv preprint presence of anosmia/hyposmia, and body pain, in this specific order, were independent predictors for COVID-19. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint 

There was a correlation between the frequency of SARS-COV-2 detection and the week of testing with the HCP incidence curve appearing to be parallel with the Non-HCP incidence curve (Figure 1) . is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted October 26, 2020. 

Although COVID-19 is known for its wide variety of clinical symptoms, we were able to identify some differences between casual and continuous reports. Findings of fever, anosmia or hyposmia, body pain, and chills were found to be linked to a 72% probability for a positive diagnosis, making these the most reliable clinical symptoms of infection.

While this initiative was initially designed to support HCP at our institution, the dire need of expansive clinical support and diagnosis for COVID-19 meant that, from week two, we included patients from other public institutions and patients frequently treated at our facility in our testing cohort. This meant that while most of the individuals (80%) evaluated and tested at our site were HCP, 20% of the study cohort comprised Non-HCP patients. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted October 26, 2020. ; https://doi.org/10.1101/2020. 10.22.20217851 doi: medRxiv preprint The HCP group predominantly comprised self-identified white professionals (55.5%) with at least 12 years of study (80.1%) while only 42.2% of the individuals in the non-HCP group identified as white. The Non-HCP group had a higher frequency of obesity (11.1% vs 4.4%) compared to that in the HCP group which was reflected in the BMI values (Non-HCP: 29.2±6.0 vs HCP: 27.4±5.2). Additionally, smoking was also more frequent in the Non-HCP group, and there were also differences in adherence to the influenza vaccination scheduled between these two groups.

As of April 8, 2020, the deadline for data collection, Brazil had reported a total of 15,927 confirmed cases of COVID-19.

[3] The State of Rio de Janeiro had 1,938 cases with this study representing 21.6% of all the cases reported in this state, with the majority of these cases being reported in HCP.

Here, we noted that detection of the SARS-COV-2 RNA in NPS is associated with the onset of COVID-19

symptoms. This data is consistent with previous studies which identifies that the virus is detectable within the first eight days of symptoms [4, 5] and reinforces the need for a differentiated strategy for determination of eligibility for NPS SARS-COV-2 testing, especially where the health system is constrained in terms of both human resources and the availability of test kits. Early recognition of COVID-19 is critical for the isolation of infected persons and the mitigation of community spread. [6] The ability to rule-out COVID-19 earlier enables more effective public health containment measures and frees up resources by reducing isolation time in suspected cases. Our study suggests that there is sufficient viral load to allow a positive NPS result within 3-4 days of infection, and this may significantly reduce isolation times, thus freeing up many valuable resources.

Headache, body ache, fever, anosmia or hyposmia, and chills were common symptoms and were more frequent among SARS-COV-2 NPS-positive patients than in SARS-COV-2 NPS-negative patients. These are wellknown signs and symptoms of various viral infections and COVID testing should be reliant on a combination of these symptoms and a comprehensive understanding of the patients' local, regional, and travel history especially in resource-constrained conditions. HCP should treat any patient with these symptoms and a high likelihood of exposure as SARS-CoV-2-positive even in the absence of an appropriate test. Zhang et al. [7] . CC-BY-NC-ND 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted October 26, 2020. ; https://doi.org/10.1101/2020.10.22.20217851 doi: medRxiv preprint observed fever (91.7%), cough (75.0%), fatigue (75.0%), and gastrointestinal symptoms (39.6%) in their COVID-19 cohort. In a meta-analysis, Li and colleagues [5] reported that fever (88.5%), cough (68.6%), myalgia or fatigue (35.8%), expectoration (28.2%), and dyspnea (21.9%) were all primary indicators of COVID-19. In this study, we also investigated if the combination of signs and symptoms could help in developing a decisionmaking rationale for ordering laboratory tests. Curiously, an increase in the frequency of anxiety and "difficulty in swallowing" was observed among those patients with inconclusive SARS-COV-2 NPS results. Psychological aspects and global mental health have already been the subject of a number of studies, as the mental toll of the patient becomes more evident. [8] [9] [10] In China, more than 70% of the patients experience moderate to high levels of psychological symptoms, specifically elevated scores for obsessive compulsion, interpersonal sensitivity, phobic anxiety, and psychoticism. [11] Our results did not corroborate those of Zhang and colleagues [12] , who showed a higher prevalence of insomnia (38.4% vs. 30.5%, p < 0.01) and anxiety (13.0% vs. 8.5%, p < 0.01) in Non-HCP (n = 1,255) patients, while we found no differences in the prevalence of anxiety between HCP and Non-HCP in our study. This may be due to the methodology used, as this study was not designed to compare these two groups. It is not possible to further characterize the work and professional activity of our participants but it is worth noting that there have been other studies that have identified differences in anxiety and stress among medical and nursing staff [13] .

Anosmia is a frequent symptom [14] of COVID-19 and is often the only indicator in asymptomatic carriers. [15] This symptom is transient and it has been suggested that this anosmia is linked to the destruction of the epithelial cells in the nose. These cells have a high expression of angiotensin converting enzyme 2, the receptor for SARS-CoV-2, which allows the virus to penetrate the system. [16] Dyspnea is a well-characterized symptom of COVID-19 and has been shown to be closely related to the severity of the disease and mortality rates. [17, 18] Our study did not evaluate disease severity, but rather focused on identification of clinical and laboratory data that could be used to predict COVID-19 infection in HCP, in an effort to allow for their rapid isolation to prevent wide spread infections among the hospital staff.

Our results showed that anosmia / hyposmia (p < 0.0001), fever (p < 0,0001), body pain (p < 0.0001), and chills (p = 0.001), in this specific order, were independent predictors for SARS-COV-2 NSF detection. Moreover, the . CC-BY-NC-ND 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted October 26, 2020. ; https://doi.org/10.1101/2020. 10.22.20217851 doi: medRxiv preprint combination of these symptoms has a prognostic capacity of around 72% for SARS-COV-2. This information should guide healthcare workers in determining the course of evaluations including laboratory testing, while allowing for the fact that the COVID-19 pandemic may contribute to revisions in the State and Municipal health authority guidelines for clinical testing and isolation.

The laboratory results indicate that the total leukocytes, % of monocytes, eosinophils, RCP, and platelet counts were all independent predictors of COVID-19. These factors were also identified in several previous COVID-19

studies. [5 19 20] In this study, we were able to combine signs, symptoms, and laboratory results in a logistic regression analysis that identified various independent predictor values that could be used to supplement RT-PCR testing in resource scarce environments. Leukocyte counts of under 5,400/µL, relative monocytosis (>9%), eosinopenia, and elevated RCP within the first seven days from the onset of fever, anosmia / hyposmia, and body pain were the main independent variables associated with positive RT-PCR results. Although platelets also appeared to be an independent predictor, the range for this value remained within the clinical reference values and would need to be compared with previous results from the same patient to be of a significant value.

Additionally, the cut-off points for leukocyte counts and percentage of monocytes may also guide the interpretation of the complete blood cell count during the first days of infection. Additionally, these results may also be used during follow-up for hospitalized patients when AST, ALT, gamma-GT, LDH, and alpha-HBDH are all markedly altered [21] .

The risk factors reported here may be used in future studies to evaluate associated medical interventions, hospitalization, and mortality rates. This cohort should also be expanded and new longitudinal evaluations should be undertaken to better understand the condition of these patients in a post pandemic future.

Nonetheless, we were able to confirm a greater risk for infection in HCP. It is well known that HCP are subject to far greater continuous exposure to COVID-19 than the general public, thus increasing their infection rates.

Noteworthy, this screening started at the beginning of the epidemic in Brazil and that the number of detected cases in this study retained a linear scale, suggesting that early infections with COVID-19 were more prevalent among HCP and for this reason close monitoring of this population might be crucial to reducing the burden on the healthcare system. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted October 26, 2020. ; https://doi.org/10.1101/2020. 10.22.20217851 doi: medRxiv preprint This study has several limitations associated with the fact that it is a cross-sectional, ongoing study, with an increasing number of patients. Although limited in number, data here may support other studies so that in the long term a better meta-analysed prediction system can be developed. The HCP population is predominantly made up of younger people and this may cause differences in the observations of this study versus studies conducted in older populations. [22 23 ] Currently, laboratory-based RT-PCR is the recommended test for diagnoses of acute cases to ensure patients can be identified and isolated and to facilitate the public health In conclusion, po sitive SARS-COV-2 NPS assays were associated with fever, anosmia or hyposmia, body pain, and chills, and patients were all positive within the first 3-8 days after symptom onset. Elevated CRP, leukocyte counts under 5,400 /µL, and relative monocytosis (>9%) were all common among patients with COVID-19.

These parameters may help to identify and isolate probable SARS-CoV-2 infections in the absence of RT-PCR tests.

• Healthcare professionals (HCP) working at the frontline are among the groups most affected by the COVID-19 pandemic. We investigated the clinical features of 1,297 individuals, mostly (80%) HCP, who tested positive for the SARS-CoV-2 (COVID-19) during the period immediately following the pandemic declaration in Brazil (March 19 to April 8, 2020). • Signs and symptom data and blood samples were collected for all individuals who were tested for SARS-CoV-2 by RT-PCR assays in nasopharyngeal swab (NPS). • CRP, LDH, AST, and ALT were elevated among COVID-19-infected individuals, and leukometry differed between individuals within the different SARS-COV-2 NPS detection results. Anosmia/hyposmia, fever, body pain, and chills, in this specific order, were independent predictors for COVID-19. The estimated . CC-BY-NC-ND 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted October 26, 2020. ; https://doi.org/10.1101/2020.10.22.20217851 doi: medRxiv preprint probability of COVID-19 detection when all four of these signs and symptoms were present was 72%. There was a trend of increasing number of SARS-CoV-2-positive test results in later weeks of analysis especially in HCP samples.

• Here, we identified that the significant clinical features of SARS-CoV-2 in Brazil included anosmia, fever, chills, body pain, elevated CRP, leukocytes under 5,400 x 10 9 /L, and relative monocytosis (>9%). These variables may help, in the absence of RT-PCR tests, to monitor the COVID-19 infection rate during a pandemic.

None to declare.

development. We would like to thank Ana Clara Perrone and Editage (www.editage.com) for English language editing.

. CC-BY-NC-ND 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted October 26, 2020. ; https://doi.org/10.1101/2020. 10.22.20217851 doi: medRxiv preprint 

The Laboratory of Histocompatibility and Cryopreservation received a thermocycler and a -80C freezer from COVID-19 donation open account for Pedro Ernesto University Hospital. Rio de Janeiro Health Secretary provided nucleic acid extraction and RT-PCR kits. Authors contribution: Study conception and design

Electronic Data Acquisition

Critical revision: C. H. Costa and I. Bouzas All authors approved the final manuscript. References 1. WHO. Coronavirus disease (COVID-19) outbreak situation

Escalating infection control response to the rapidly evolving epidemiology of the Coronavirus disease 2019 (COVID-19) due to SARS-CoV-2 in Hong Kong

novel coronavirus patients' clinical characteristics, discharge rate and fatality rate of meta-analysis

Rapid viral diagnosis and ambulatory management of suspected COVID-19 cases presenting at the infectious diseases referral hospital

Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan

Epidemic of COVID-19 in China and associated Psychological Problems

A multinational, multicentre study on the psychological outcomes and associated physical symptoms amongst healthcare workers during COVID-19 outbreak

COVID-19 pandemic and its impact on mental health of healthcare professionals

Psychological symptoms of ordinary Chinese citizens based on SCL-90 during the level I emergency response to COVID-19

Mental Health and Psychosocial Problems of Medical Health Workers during the COVID-19 Epidemic in China

Generalized anxiety disorder, depressive symptoms and sleep quality during COVID-19 outbreak in China: a web-based cross-sectional survey

Presentation of new onset anosmia during the COVID-19 pandemic

Possible link between anosmia and COVID-19: sniffing out the truth

SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes

Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis

Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis

Laboratory abnormalities in patients with COVID-2019 infection

Hematologic parameters in patients with COVID-19 infection

A comparative study on the clinical features of COVID-19 pneumonia to other pneumonias

Clinical features of COVID-19 in elderly patients: A comparison with young and middle-aged patients

Clinical Features of 85 Fatal Cases of COVID-19 from Wuhan: A Retrospective Observational Study

We thank all team at the front line for reception of patients, security and cleaning services. Undergraduate, interns and residents acting as volunteers were also deeply acknowledge. We also thank Carlos Nunes, Andrea Benazzi, Karina Goulart, Tainah Lima, Miguel Garcia, Breno Sampaio and Marcos Alcoforado for data entry and Mário João Junior for electronic entry data